Lars Otto Uttenthal

Technik-/Wissenschafts-/F&E-Leiter bei PHARMA EQUITY GROUP A/S

79 Jahre

Health Technology

Consumer Services

Finance

Aktive Positionen von Lars Otto Uttenthal

Unternehmen	Position	Beginn	Ende
PHARMA EQUITY GROUP A/S	Technik-/Wissenschafts-/F&E-Leiter	-	-
Bioporto Diagnostics A/S Bioporto Diagnostics A/S BiotechnologyHealth Technology Part of Bioporto A/S, Bioporto Diagnostics A/S is a Danish company that engages in research and experimental development on biotechnology. The company is based in Gentofte, Denmark. Peter Morch Eriksen has been the CEO of the company since 2013.	Direktor/Vorstandsmitglied	26.05.2010	-
AKI Therapeutics ApS AKI Therapeutics ApS Pharmaceuticals: MajorHealth Technology AKI Therapeutics ApS is a Danish pharmaceutical company that manufactures pharmaceutical products. The private company is based in Hørsholm, Denmark and was founded in 2016.	Direktor/Vorstandsmitglied	-	-

Unternehmen	Position	Beginn	Ende
BIOPORTO A/S	Technik-/Wissenschafts-/F&E-Leiter	26.05.2010	-

University of Oxford

Doctorate Degree

International

Dänemark	5
Vereinigtes Königreich	2

Operativ

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	2
BIOPORTO A/S	Health Technology
PHARMA EQUITY GROUP A/S	Finance

Private Unternehmen	2
Bioporto Diagnostics A/S Bioporto Diagnostics A/S BiotechnologyHealth Technology Part of Bioporto A/S, Bioporto Diagnostics A/S is a Danish company that engages in research and experimental development on biotechnology. The company is based in Gentofte, Denmark. Peter Morch Eriksen has been the CEO of the company since 2013.	Health Technology
AKI Therapeutics ApS AKI Therapeutics ApS Pharmaceuticals: MajorHealth Technology AKI Therapeutics ApS is a Danish pharmaceutical company that manufactures pharmaceutical products. The private company is based in Hørsholm, Denmark and was founded in 2016.	Health Technology